In summary, RGS9-deficient mice show significant changes in striatal function including enhanced DARPP32 and ERK phosphorylation that are characteristically found in L-DOPA-induced dyskinesia [59], [67]. The gene discussed is MAPK1; the disease is drug-induced dyskinesia.